Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Acta Pharmacologica Sinica2015Vol. 36(10), pp. 1219–1227
Citations Over TimeTop 10% of 2015 papers
Abstract
Recent studies have revealed extensive genetic and non-genetic variation across different geographical regions of a tumor or throughout different stages of tumor progression, which is referred to as intra-tumor heterogeneity. Several causes contribute to this phenomenon, including genomic instability, epigenetic alteration, plastic gene expression, signal transduction, and microenvironmental differences. These variables may affect key signaling pathways that regulate cancer cell growth, drive phenotypic diversity, and pose challenges to cancer treatment. Understanding the mechanisms underlying this heterogeneity will support the development of effective therapeutic strategies.
Related Papers
- → Tumour heterogeneity and resistance to cancer therapies(2017)3,630 cited
- → Tumor heterogeneity: Causes and consequences(2009)1,604 cited
- → A narrative review of tumor heterogeneity and challenges to tumor drug therapy(2021)137 cited
- → Tumor heterogeneity in neoplasms of breast, colon, and skin(2010)23 cited
- → The First Tianjin, China Forum on Tumor Microenvironment(2011)6 cited